SPS - Specialist Pharmacy Service
The first stop for professional medicines advice
About
Log in
Register
NHS
Guidance
Guidance
Guidance index
Search Guidance
Guidance by Care Setting
Adults
Care homes
Care of the elderly
Community Health Services
Critical care
Dentistry
Emergency medicine and urgent care
Health and Justice
Neonates
Occupational Health
Paediatrics
Palliative and End of Life Care
Primary Care
Transfer of care
Trusts
Guidance by Specialty
Allergy and immunology
Anaesthesia and pain
Cancers
Cardiovascular system disorders
Diabetes
Endocrine system disorders
Eyes and vision
Gastrointestinal disorders
Haematological disorders
Infection and infectious diseases
Mental health and illness
Neurological disorders
Nutritional and metabolic disorders
Obstetrics and gynaecology
Public Health
Radiology
Renal and urologic disorders
Reproductive health
Respiratory disorders
Sexual health
Skin disorders
Vaccinating
Wounds and injuries
Events
Events
Events index
Search Events
Events by Care Setting
Community Health Services
Health and Justice
Primary Care
Events by Guidance area
Advanced therapy medicinal products
Adverse effects
Aseptic services
Clean rooms
Medication Safety
Patient Group Directions
Preparing
Safety in Pregnancy
Events by Specialty
Endocrine system disorders
Infection and infectious diseases
Mental health and illness
Neurological disorders
Planning
Planning
Planning index
Search Medicines planning
Planning by Care Setting
Transfer of care
Trusts
Planning by Specialty
Eyes and vision
Musculo-skeletal disorders
Neurological disorders
Training
Training
Training index
Search Training and Development
Publications
Publications
Publications index
Search Publications
Publications by Care Setting
Emergency medicine and urgent care
Health and Justice
Publications by Specialty
Infection and infectious diseases
Neurological disorders
Public Health
Radiology
Renal and urologic disorders
Reproductive health
Respiratory disorders
Sexual health
Skin disorders
Tools
Medicines Tools
Medicines Tools index
Search
Home
Search
‘Biosimilar’
42 results
Filter
Care Setting
(8)
Primary Care
(2)
Transfer of care
(2)
Trusts
(6)
Events
(1)
Past Events
(1)
Guidance
(10)
Aseptic services
(1)
Homecare
(3)
Policy, Commissioning and Managerial
(3)
Preparing
(1)
Prescribing
(2)
Stability of cytotoxics
(1)
Switching
(2)
Unlicensed medicines
(1)
Medicine
(14)
Adalimumab
(1)
Adrenaline
(1)
Beclometasone
(1)
Beclometasone + Formoterol
(1)
Budesonide
(1)
Budesonide + Formoterol
(1)
Buprenorphine
(1)
Carbamazepine
(1)
Ciclosporin
(1)
Diltiazem
(1)
Eculizumab
(3)
Fentanyl
(1)
Fluticasone
(1)
Fluticasone + Formoterol
(1)
Fluticasone + Salmeterol
(1)
Lithium
(1)
Lithium carbonate
(1)
Mesalazine
(1)
Methylphenidate
(1)
Morphine
(1)
Mycophenolate mofetil
(1)
Natalizumab
(3)
Nifedipine
(1)
Oxycodone
(1)
Phenobarbital
(1)
Phenytoin
(1)
Primidone
(1)
Ranibizumab
(3)
Tacrolimus
(1)
Tiotropium
(1)
Tocilizumab
(3)
Tramadol
(1)
Medicines planning
(22)
Biosimilars
(20)
New Medicines
(5)
CCG commissioned new medicines
(3)
NHS England commissioned new medicines
(3)
Patent expiries
(1)
Specialty
(9)
Eyes and vision
(3)
Musculo-skeletal disorders
(3)
Neurological disorders
(3)
Training and Development
(1)
Stability Part 2 Biopharmaceuticals v5 ·
784.31 KB
2 July 2021
·
or where
biosimilars
exist. 2.2 Although published studies for monoclonal antibodies are improving in
National Homecare Medicines Committee (NHMC) Proposal for the funding of Pharmacy Homecare Teams
4 May 2018
·
Biosimilars
NHMC Good Practice Principles for the Provision of Manufacturer Funded Homecare Services
5 March 2018
·
Biosimilars
National Homecare Medicines Committee (NHMC) Homecare Risk Assessment
10 December 2019
·
Biosimilars
NHMC Homecare Risk Assessment ·
93.38 KB
10 December 2019
·
Likelihood: scenarios include manufacturer-commissioned service of a brand nearing patent expiry - generic/
biosimilar
App 19 slide deck NHS training ·
4.64 MB
2 July 2018
·
the Generic Medicines subgroup, the Branded and
Biosimilar
subgroup and the National Homecare Medicines
SPS are going to CPC London 2024
28 March 2024
·
New generics and
biosimilars
at 17.30 Jackie Eastwood talked with a colleague about maximising uptake
Procurement of licensed medicines
12 November 2021
·
This excludes
biosimilars
.
SPS Horizon Scanning
20 January 2024
·
of new medicines or licence extensions over the current and next financial year (excluding ATMPs and
biosimilars
"Tranche" branded medicines in a competitive market
12 November 2021
·
following therapeutic categories: Cytokine modulators miscellaneous monoclonal antibodies (including some
biosimilars
Previous
1
2
3
4
5
Next